Other Issues

Today, CHPA announced a new initiative to support retailers in states that have adopted laws prohibiting the sale of OTC medicines containing the cough suppressant dextromethorphan to minors. The announcement comes on the heels of Nevada’s enactment of a DXM age-restriction law last week.

CHPA applauds AHPA’s new guidelines on Good Agricultural and Collection Practices and Good Manufacturing Practices for Botanical Material, and acknowledges their importance in helping to ensure the production and supply of high-quality herbal raw materials.

To combat teen abuse of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM), Oregon Governor Kate Brown today signed legislation prohibiting the sale of DXM-containing products to minors.

This week, Nevada Governor Brian Sandoval signed legislation prohibiting the sale of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM) to minors.

The dietary supplement industry’s self-regulatory coalition, the SIDI Work Group, today released an updated draft of the “Standardized Information on Dietary Ingredients (SIDI) Protocol,” and seeks feedback from industry stakeholders and regulators by July 3, 2017.

A newly published article in the medical journal Pediatrics concludes that over-the-counter (OTC) cough and cold medicines for children are safe when used and stored as directed.

CHPA applauds CRN and UL for spearheading the Supplement OWL, which will prove to be a valuable resource for regulators, retailers and ultimately consumers.